ArticleFrontiers in oncology2023

Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.

Christopher M Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.